Global Core Needle Biopsy for Soft Tissue Market Growth 2023-2029

Global Core Needle Biopsy for Soft Tissue Market Growth 2023-2029

A core needle biopsy is a procedure where a doctor takes a sample from a suspicious lump or area of tissue. The report mainly studies core biopsy needles.

LPI (LP Information)' newest research report, the “Core Needle Biopsy for Soft Tissue Industry Forecast” looks at past sales and reviews total world Core Needle Biopsy for Soft Tissue sales in 2022, providing a comprehensive analysis by region and market sector of projected Core Needle Biopsy for Soft Tissue sales for 2023 through 2029. With Core Needle Biopsy for Soft Tissue sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Core Needle Biopsy for Soft Tissue industry.

This Insight Report provides a comprehensive analysis of the global Core Needle Biopsy for Soft Tissue landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Core Needle Biopsy for Soft Tissue portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Core Needle Biopsy for Soft Tissue market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Core Needle Biopsy for Soft Tissue and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Core Needle Biopsy for Soft Tissue.

The global Core Needle Biopsy for Soft Tissue market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Core Needle Biopsy for Soft Tissue is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Core Needle Biopsy for Soft Tissue is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Core Needle Biopsy for Soft Tissue is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Core Needle Biopsy for Soft Tissue players cover BD, Medtronic, IZI Medical, Medax, ARGON MEDICAL, Ranfac, Merit Medical and INRAD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Core Needle Biopsy for Soft Tissue market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Below 10 cm
10-15 cm
15-20 cm
Above 20 cm

Segmentation by application
Hospitals & Clinics
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Medtronic
IZI Medical
Medax
ARGON MEDICAL
Ranfac
Merit Medical
INRAD

Key Questions Addressed in this Report

What is the 10-year outlook for the global Core Needle Biopsy for Soft Tissue market?

What factors are driving Core Needle Biopsy for Soft Tissue market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Core Needle Biopsy for Soft Tissue market opportunities vary by end market size?

How does Core Needle Biopsy for Soft Tissue break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.